[1]
H. Raza, M. E. Bhutta, and M. H. Siddique, “Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus”, Sultan Qaboos Univ Med J, vol. 24, no. 3, pp. 418–419, Aug. 2024.